0 items

in your cart

Prescription Drug Search

Product Request Form

Nplate is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Nplate becomes available, please fill out the form below.


*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Nplate:

  • Albania
  • Argentina
  • Armenia
  • Barbados
  • Bolivia
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Colombia
  • Cuba
  • Cyprus
  • Ecuador
  • El Salvador
  • Estonia
  • Fiji
  • Finland
  • Greece
  • Guatemala
  • India
  • Indonesia
  • Ireland
  • Italy
  • Jamaica
  • Latvia
  • Mauritius
  • Moldova, Republic of
  • Monaco
  • Morocco
  • Netherlands Antilles
  • Poland
  • Romania
  • Slovakia
  • Slovenia
  • South Africa
  • Trinidad and Tobago
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Uzbekistan
  • Yemen
View All Countries

Latest news releases on Nplate:

FDA has approved Nplate for treatment of chronic immune thrombocytopenic purpura - Xagena Medical News

The FDA ( Food and Drug Administration ) has approved Nplate ( Romiplostim ), the first product that directly stimulates the bone marrow to produce needed platelets in patients with chronic immune thrombocytopenic purpura, a rare blood disorder that can ...

Fitch Rates Amgen's Senior Notes 'BBB' - TMCnet

Uptake of the new medicines as well as demand increases for Nplate, Vectibix, and Sensipar fully offset the negative demand pressures on the maturing product portfolio from brand name and biosimilar competition, and government reimbursement ...

Research and Markets: Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - Boston Globe

The market witnessed significant growth during 2006-2011 owing to the launch of Nplate (romiplostim) in 2008 in the US and in Europe in 2009. In addition to this, Promacta/Revolade (eltrombopag) was launched in the US in 2009 and in Europe in 2010.

Orphan Disease Therapeutics Market to 2018 - SBWire

Increasing awareness of the disease and drugs among patients and physicians, patent protection and exclusivity of Nplate and Promacta for ITP market, anticipated launch of new molecules such as ACR-16, AMR-101 and HD-02 for the treatment of HD and the ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK